HOME >> BIOLOGY >> NEWS
Clearing the brain of amyloid peptides

Although the synthesis and pathological role of amyloid peptides are matters of great interest and controversy, the opposing process of amyloid clearance from the brain has received far less attention. Derived from the amyloid precursor protein, the amyloid b1-40 peptide is found in soluble form in the interstitial fluid of the brain, as well as in plaques that form in the brains of individuals with Alzheimers disease (AD). This peptide also interacts with numerous cell surface proteins, such as the LDL receptor-related proteins LRP-1 and -2, and with secreted proteins such as apolipoprotein E. Here, Shibata et al. analyze the kinetics of efflux of this peptide by injecting it in radiolabeled form into the brains of mice. They show that the peptide is cleared from the central nervous system primarily by vascular transport and that the peptide is not degraded by local proteinases but remains stable until it crosses the blood-brain barrier. This vascular transport is significantly less efficient in older mice, suggesting a possible explanation of the age-dependence of AD. The authors also show that interfering with LRP-1 partially blocks the efflux of the peptide, and they suggest that the downregulation of this receptor could account for both the timing and the tissue localization of amyloid in AD patients. Shibata and coworkers have also tested the efflux of amyloid b1-40 peptide in ApoE-deficient mice. Their finding that amyloid clearance is diminished in these mice suggests a previously unsuspected role for ApoE in this disease pathway, distinct from its putative role in amyloidogenesis. If confirmed, this finding could complicate the interpretation of genetic variation in ApoE and its relevance to the risk of AD.


'"/>

Contact: John Hawley
j.hawley@the-jci.org
734-936-2685
Journal of Clinical Investigation
12-Dec-2000


Page: 1

Related biology news :

1. Conservation Biology Clearinghouse, Engineering Design Tutor
2. Trial shows which brain cancer patients benefit from temozolomide
3. Targeted therapy knocks out pediatric brain cancer in mice
4. New way to protect brain from stroke damage
5. Chemical signals health of brain cells Symposium
6. DHA-rich diet protects brain from Alzheimers damage, UCLA study shows
7. Decreasing toxins in brains of Alzheimers patients keep cognitive deficits at bay
8. Genetic clues found for common congenital brain disorder
9. Marijuana ingredient inhibits VEGF pathway required for brain tumor blood vessels
10. Molecular therapeutics advance fight against brain cancer
11. Depression traced to overactive brain circuit

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/11/2017)... DUBLIN , Apr. 11, 2017 Research ... Tracking Market 2017-2021" report to their offering. ... The global eye tracking market to grow at ... The report, Global Eye Tracking Market 2017-2021, has been prepared based ... report covers the market landscape and its growth prospects over the ...
(Date:4/11/2017)... 2017 NXT-ID, Inc. (NASDAQ:   NXTD ... the appointment of independent Directors Mr. Robin D. Richards ... of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief ... to their guidance and benefiting from their considerable expertise as ...
(Date:4/5/2017)... 2017  The Allen Institute for Cell Science today ... one-of-a-kind portal and dynamic digital window into the human ... first application of deep learning to create predictive models ... and a growing suite of powerful tools. The Allen ... future publicly available resources created and shared by the ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... ... Lithuania, announced today that they have entered into a multiyear collaboration to identify ... CRISPR researchers with additional tools for gene editing across all applications. , Under ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... pharmaceutical and biotechnology industries to improve patient outcomes and quality of life, will ... analytical testing are being attributed to new regulatory requirements for all new drug ...
(Date:10/11/2017)... ... October 11, 2017 , ... The ... context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The ... transformative for performing systematic gain-of-function studies. , This complement to loss-of-function studies, ...
(Date:10/11/2017)... ... October 11, 2017 , ... Proscia Inc ... hosting a Webinar titled, “Pathology is going digital. Is your lab ready?” with ... adoption best practices and how Proscia improves lab economics and realizes an increase ...
Breaking Biology Technology:
Cached News: